Dr. Roy Perlis is Staff Psychiatrist for the Massachusetts General Hospital Bipolar Research Program and the Depression Clinical Research Program in Boston. In addition, he is a psychiatry instructor at Harvard Medical School in Boston.
Dr. Perlis earned his undergraduate degree at Brown University in Providence, Rhode Island, and his MD at Harvard Medical School. After graduating, he completed his residency in adult psychiatry at Massachusetts General Hospital and McLean Hospital in Belmont, Massachusetts, where he was designated Chief Resident in Psychopharmacology. His fellowship also was conducted at Massachusetts General Hospital.
Dr. Perlis’ research interests include pharmacogenetics and predictors of treatment response in mood disorders. He has authored articles, book chapters, and reviews concerning topics in his field. His articles are published in prestigious scientific journals, such as American Journal of Psychiatry and Journal of Clinical Psychopharmacology. To his credit, he is coauthor of the American Psychiatric Association’s Bipolar Treatment Guidelines. Dr. Perlis is the recipient of the National Alliance for Research on Schizophrenia Award, the American Philosophical Society Award, and the New Clinical Drug Evaluation Unit Award sponsored by the National Institute of Mental Health.
Genomind LLC, Healthrageous, PamLab, Proteus Biomedical, RID Ventures
Concordant Rater Systems (now Medco)
Last updated: 10/4/2012